Literature DB >> 783030

Attempts at perfect normalization of glucose tolerance test of severe diabetics by artificial beta cell.

W Kerner, C Thum, G Tamás, W Beischer, A H Clemens, E F Pfeiffer.   

Abstract

The artificial beta cell is a Glucose Controlled Insulin (and dextrose) Infusion System (GCIIS) for maintaining normoglycemia in diabetic conditions and other disturbances of metabolism. The insulin and dextrose infusion rates are calculated by a microcomputer according to the static glucose concentration (proportional control) and to its rate of change (dynamic control). The algorithms controlling the computer can be adapted to the subjects' requirements. It has already been shown, that the artificial beta cell is able to maintain blood sugar values in diabetics within physiological ranges during the course of the day. In our present study we examined the response of the artificial beta cell using a 100 gm oral glucose load in severe diabetics. The first type of control algorithms applied effected a rather small initial insulin infusion following OGTT in 8 juvenile diabetics connected with the artificial beta cell. The glucose responses thus obtained were similar to latent diabetes. In contrast, when the computer was controlled by the second type of algorithms with a more responsive dynamic control and a consequently higher initial insulin infusion, in one diabetic OGTT was fully normalized, whereas an improvement was achieved in another diabetic patient. Furthermore it was shown that control algorithms must be varied individually, depending on residual beta cell function and glucose regulatory mechanisms.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 783030     DOI: 10.1055/s-0028-1093650

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  13 in total

1.  Differential and integral corticosteroid feedback effects on ACTH secretion in hypoadrenocorticism.

Authors:  H L Fehm; K H Voigt; G Kummer; R Lang; E F Pfeiffer
Journal:  J Clin Invest       Date:  1979-02       Impact factor: 14.808

Review 2.  Recent developments in insulin delivery techniques. Current status and future potential.

Authors:  F P Kennedy
Journal:  Drugs       Date:  1991-08       Impact factor: 9.546

3.  Evaluation of exogenous insulin homoeostasis by the artificial pancreas in insulin-dependent diabetes.

Authors:  J Mirouze; J L Selam; T C Pham; D Cavadore
Journal:  Diabetologia       Date:  1977-05       Impact factor: 10.122

4.  Optimal feedback glycaemia regulation in diabetics.

Authors:  G Bellomo; P Brunetti; G Calabrese; D Mazzotti; E Sarti; A Vincenzi
Journal:  Med Biol Eng Comput       Date:  1982-05       Impact factor: 2.602

5.  Preserved incretin effect in type 1 diabetic patients with end-stage nephropathy treated by combined heterotopic pancreas and kidney transplantation.

Authors:  M A Nauck; M Büsing; C Orskov; E G Siegel; J Talartschik; A Baartz; T Baartz; U T Hopt; H D Becker; W Creutzfeldt
Journal:  Acta Diabetol       Date:  1993       Impact factor: 4.280

6.  On the way to the automated (blood) glucose regulation in diabetes: the dark past, the grey present and the rosy future. XII Congress of the International Diabetes Federation, Madrid, 22-28 September 1985.

Authors:  E F Pfeiffer
Journal:  Diabetologia       Date:  1987-02       Impact factor: 10.122

7.  Assessment of an algorithm for the artificial B-cell using the normal insulin-glucose relationship in diabetic dogs and men.

Authors:  U Fischer; E Jutzi; H Bombor; E J Freyse; E Salzieder; G Albrecht; W Besch; W Bruns
Journal:  Diabetologia       Date:  1980       Impact factor: 10.122

8.  Pattern of insulin delivery after intravenous glucose injection in man and its relation to plasma glucose disappearance.

Authors:  E Ferrannini; A Pilo
Journal:  J Clin Invest       Date:  1979-07       Impact factor: 14.808

9.  [Human C-peptide. Part III: dynamics of secretion of beta-cells in adult diabetics following glibenclamide-glucose i.v. (human C-peptide III) (author's transl)].

Authors:  W Beischer; S Raptis; L Keller; M Maas; B Beischer; K Feilen; E F Pfeiffer
Journal:  Klin Wochenschr       Date:  1978-02-01

10.  Glucose control in mobile type 1 (insulin-dependent) diabetic patients by means of a semi-automatic feedback controlled insulin infusion system.

Authors:  K Piwernetz; R Renner; K D Hepp
Journal:  Diabetologia       Date:  1982-09       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.